Friday, January 21, 2022

MonoClonal..

 




The use of some monoclonal antibody treatments against COVID is now being discouraged, and updated guidelines from the NIH COVID Treatment Panel say Regeneron and Eli Lilly's treatments have been shown to fail against omicron.

Officials said Sotrovimab is the only monoclonal antibody treatment for COVID that has so far been shown to hold up against omicron.

Hospitals, drug companies and Biden administration officials are racing to address one of the Omicron variant’s biggest threats: Two of the three monoclonal antibody treatments that doctors have depended on to keep Covid-19 patients from becoming seriously ill do not appear to thwart the latest version of the coronavirus.

The one such treatment that is still likely to work against Omicron is now so scarce that many doctors and hospitals have already run through their supplies. 

It is a new era today. When the Biden's administration thought they got the hang of it with 850,000 Death from Covid, a new threat to Biden's Ego appears. With that the lies that was rerouted repeatedly is clearing out.

Just a thought.

Thursday, January 20, 2022

Suck-cess..

 




Doing..

 


How Am I doing? 
This is not a fair question. You know the answer.
Whatever this President think of success has no meaning to regular people who find heating their homes cost three folds of what it cost the year before. 

Find the cost of living, food and services is twice as much, and the cost of driving to work cost three folds of what it was.

But your success is simple. Looking for a Black woman nomination for the highest court, supreme court. Just a thought.

Elect..

 




Fourth..

 


The fourth shot of the COVID-19 vaccine boosts antibodies but doesn’t provide enough protection to prevent infections from the Omicron variant, according to new research at an Israeli hospital.

The preliminary results, released on Monday, challenge the idea of giving a second booster dose to slow the spread of the coronavirus, according to USA Today.

Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus.

In a clinical trial, 274 medical workers at Sheba Medical Center near Tel Aviv received a fourth vaccine dose in December -- 154 got the Pfizer vaccine and 120 got the Moderna vaccine -- after previously getting three Pfizer shots.

Both groups received a boost in antibodies that was “slightly higher” than after the third shot, Regev-Yochay said. But when compared to a control group that didn’t receive the fourth dose, the extra boost didn’t prevent the spread of Omicron.

Let us invest in a different, Covid tweaked vaccines that target the virus, instead of keep boosting people unnecessary. Just a thought.

Wednesday, January 19, 2022

Sighted..

 


Explain..

 




Evade..

 

A new study from researchers at Columbia University suggests the omicron variant of COVID-19 is “markedly resistant” to the current COVID-19 vaccines, antibody treatments and booster shots, raising concern from experts about what’s to come from the variant in the coming weeks.  

“We found (omicron) to be markedly resistant to neutralization by serum not only from convalescent patients, but also from individuals vaccinated with one of the four widely used COVID-19 vaccines. Even serum from persons vaccinated and boosted with mRNA-based vaccines exhibited substantially diminished neutralizing activity against B.1.1.529,” the study, which was done by researchers at the Columbia University Irving Medical Center and the University of Hong Kong.

The Columbia University study found that monoclonal antibody cocktails are ineffective against omicron, too.

“Our booster vaccine regimens work against omicron,” said Dr. Anthony Fauci, scientist/Politician.  Just a "scientific" thought.